Also do the Math JGD....
"THE FEE!
There is also the license fee! Now what is the fee based on? The fee is usually based upon the costs that the company accumulated bringing the product to market. The costs include trials, FDA, soft costs and other expenses that were incurred. Plus a little incentive for BIEL. Now pending on the size of market the partner takes on would be the ratio of what the fee would be. This will be no desperate measure from BIEL to just take any amount offered to them. It’s all numbers."
Per the last financial statement, Q1 2019, BIEL had a $35.3 million Accumulated Deficit. This was all spent operating the company while bringing ActiPatch to market. There were also several million dollars in profits that were used funding the company but let's stick to the $35 mil number.
Say the new Partner wants to operate in 15% of the potential markets for ActiPatch. That could equal a $5.25 million dollar Licensing Fee to BIEL. Do the math from there based on what size of the market you feel the Partner has agreed to.
Market Data 
Markets 
AI
